Overview
- 52 inspections across 49 sites are on record.
- 45 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-29.
At a glance
Inspections
52
Sites
49
Observations
45
Career since
Oct 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Accuprec Research Labs Private Ltd | 29 Apr 2026 | Human Drugs | |
| La Chandra Pharmalab Private Limited | 24 Apr 2026 | Human Drugs | On file |
| Morepen Laboratories Limited | 17 Apr 2026 | Human Drugs | |
| RK Pharma Inc. | 27 Mar 2026 | Human Drugs | On file |
| GlaxoSmithKline LLC | 20 Feb 2026 | Human Drugs |
Sites inspected
Accuprec Research Labs Private LtdChangodar, India1 insp.
La Chandra Pharmalab Private LimitedDist.: Banaskantha, India1 insp.
Morepen Laboratories LimitedSolan, India1 insp.
RK Pharma Inc.Pearl River, United States1 insp.
GlaxoSmithKline LLCZebulon, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ankur C Patel5 shared
Annet R Rajan4 shared
Soyinka S Eneng3 shared
Kshitij A Patkar3 shared
Norman K Starks3 shared
Anthony J Donato2 shared
Victoria Spivak2 shared
Monika Borkowska2 shared
Nicholas A Violand2 shared
Lata C Mathew1 shared
Full investigator report
Get the verbatim findings behind Robin P Mathew's 45 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site